Status:

UNKNOWN

The Study of Infection and Cell Inflammation in Peritoneal Dialysate

Lead Sponsor:

National Taiwan University Hospital

Conditions:

Peritonitis

Kidney Failure

Eligibility:

All Genders

18-80 years

Brief Summary

A progressive decline of plasma triggering receptor expressed on myeloid cells-1 (TREM-1) concentration indicates a favorable clinical evolution during the recovery phase of sepsis. The expression of ...

Detailed Description

The triggering receptor expressed on myeloid cells-1 (TREM-1) is a member of the immunoglobulin superfamily, and its expression is upregulated on phagocytic cells in the presence of bacteria or fungi ...

Eligibility Criteria

Inclusion

  • peritoneal dialysis patients, dialysis period for more than 3 months.

Exclusion

  • age younger than 18 years old, Pregnant or lactating women. (Pre-menopause women, capable of bearing children will undergo pregnancy test)

Key Trial Info

Start Date :

June 1 2005

Trial Type :

OBSERVATIONAL

End Date :

June 1 2009

Estimated Enrollment :

100 Patients enrolled

Trial Details

Trial ID

NCT00173485

Start Date

June 1 2005

End Date

June 1 2009

Last Update

November 24 2005

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

National Taiwan University Hospital

Taipei, Taiwan